Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease(REAL-CAD).
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 May 2017
At a glance
- Drugs Pitavastatin (Primary)
- Indications Cardiovascular disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms REAL-CAD
- 31 Oct 2016 Planned End Date changed from 30 Sep 2018 to 30 Jun 2018.
- 17 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Oct 2011 Planned end date changed from 1 Jan 2016 to 1 Mar 2017 as reported by ClinicalTrials.gov.